Aristotle University Of Thessaloniki (AUTH)
Ανοσοπαρεμβατική δράση της κλαριθρομυκίνης στην δευτεροπαθή περιτονίτιτδα
Abstract
dc:descriptionIntroduction: Sepsis is the leading cause of death in patients suffering from secondary peritonitis, despite surgical treatment and admission in intensive care units on time. The onset of sepsis is characterized by a complex pathogen-host interaction, which leads to increased production of proinflammatory cytokines and induction of the systemic inflammatory response syndrome (SIRS). However, in the course of sepsis, an increased release of anti-inflammatory cytokines takes also place and is associated with the development of the compensatory anti-inflammatory response syndrome (CARS). This syndrome is characterized by enhanced apoptosis of immunocompetent cells, such as lymphocytes and monocytes and immunoparalysis (anergy) of monocytes and should not be underestimated, because it often leads the host to a state of immunodepression. Clinical studies have shown that increased rates of apoptosis of blood lymphocytes and monocytes are associated with decreased survival, while results from experimental studies have demonstrated that inhibition of the apoptotic process as well as of the immunoparalysis of monocytes, with the use of agents that act as immunomodulators, prolongs survival. Furthermore, recent data from experimental models of monomicrobial sepsis showed that clarithromycin, a newer macrolide with proved immunomodulatory effects in chronic inflammatory disorders of the respiratory tract, can act as an immunomodulator in acute inflammatory conditions too, thus prolonging survival of the host. Based on the above data from the literature, the present study was designed in order to examine the efficacy of clarithromycin as an immunomodulatory agent, when administered in an animal model of polymicrobial sepsis due to secondary peritonitis. Materials and methods: Cecal ligation and puncture (CLP) was performed in 60 male New Zealand rabbits, leading to secondary peritonitis. Afterwards, animals were randomly divided in 4 groups with 15 animals in each one and administered intravenously: group A, normal saline only, half an hour and 2 hours after induction of the peritonitis; group B, additionally a single dose of clarithromycin (80 mg/kg), half an hour after induction of the peritonitis; group C, additionally a single dose of piperacillin/tazobactam (400 mg/kg), 2 hours after induction of the peritonitis and group D, additionally clarithromycin and piperacillin/tazobactam in the regimens described above for groups Β and C. Survival of animals was recorded for a total follow-up period of 10 days. Animals remaining alive after 10 days were sacrificed. Autopsy was performed following death and segments from the spleen, right lobe of the liver, right kidney, lower lobe of the right lung and mesenterium were collected for quantitative and qualitative cultures. Furthermore, blood samples were taken from each animal at 2, 4, 24 και 48 hours postoperatively to estimate a) the apoptosis of lymphocytes and monocytes and b) the release of TNF-α from isolated monocytes after stimulation with LPS or Pam3Cys. Apoptosis of 73 lymphocytes and monocytes was measured with flow cytometric analysis after staining the cells with Annexin-V and propidium iodine, while the measurement of released TNF-α from isolated monocytes was based on the cytotoxic effect of TNF-α on an L929 fibrosarcoma cell line. Results: The rate of apoptosis of lymphocytes was lower in groups Β and D compared to that of groups A and C, at 4 and 24 hours postoperatively. More precisely, statistically significant differences were observed between group Β and groups A and C at 4 hours (p=0,015 and 0,028, respectively), between group Β and groups A and C at 24 hours (p=0,046 and 0,02, respectively) and between group D and groups A and C at 24 hours (p=0,008 and 0,003, respectively). Concerning the apoptosis of monocytes, statistical analysis showed that at 24 hours, groups Β and D presented significantly lower rates of apoptosis compared to these of groups A and C (group Β vs. group A p=0,020, group Β vs. group C p=0,006 and group D vs. group C p=0,023). The ex vivo release of TNF-α from isolated monocytes after stimulation with LPS was lower in groups Β and D compared to that in group A, at 2 και 4 hours after CLP; however this difference was not statistically significant. On the contrary, at 24 and 48 hours a reversal of this phenomenon was observed with animals of group Β and D presenting an increase of released TNF-α from their monocytes compared to those of groups A and C. Further statistical analysis revealed significant differences between groups Β and A (p=0,002 at 24 hours and p=0,005 at 48 hours) and groups Β and C (p=0,001 at 24 hours and p=0,003 at 48 hours). The results from quantitative and qualitative tissue cultures showed that the most commonly isolated bacterium was Escherichia Coli, followed by Enterococcus sp. and Proteus sp. Bacterial growth in tissues was significantly lower in groups C and D compared to that in group A. Finally, survival was significantly prolonged in group D compared to group A (p=0,02). Conclusions: Administration of clarithromycin in a model of polymicrobial sepsis due to secondary peritonitis, modulates the host immune response, by decreasing the rate of early apoptosis of blood lymphocytes and monocytes and the rate of immunoparalysis of monocytes, thus resulting in an increased release of TNF-α. Moreover, clarithromycin prolongs survival of the host, when co-administered with broad-spectrum antibiotics.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2011
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Atmatzidis, Stefanos
- Ατματζίδης, Στέφανος
Subjects
dc:subject × 18- Σήψη
- Σύνδρομο συστηματικής φλεγμονώδους αντίδρασης
- Σύνδρομο αντιρροπιστικής αντιφλεγμονώδους αντίδρασης
- Απόπτωση λεμφοκυττάρων και μονοκυττάρων
- Ανοσοπαράλυση μονοκυττάρων
- Ανοσοπαρέμβαση στην σήψη
- Κλαριθρομυκίνη
- Sepsis
- Systemic inflammatory response syndrome (SIRS)
- Compensatory antiinflammatory response syndrome
- Apoptosis of lymphocytes and monocytes
- Anosoparalysis of monocytes
- Immunomodulation in sepis
- Clarithromycin
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Medical and Health Sciences
- Basic Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/26060